Seoul, South Korea

Youjin Na

This inventor holds 1 USPTO granted patent. Top assignee: Genemedicine Co., Ltd.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Youjin Na. Retrieved from https://idiyas.com/inventor/youjin-na

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Youjin Na: Innovator in Gene Therapy

Introduction

Youjin Na is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of gene therapy, particularly through his innovative work with adenovirus complexes.

Latest Patents

Youjin Na holds a patent for an "Adenovirus complex for gene delivery and gene therapy." This invention relates to an adenovirus complex that targets neurotensin receptors, enabling effective gene delivery and therapy. The complex demonstrates an excellent antitumor effect due to its high intracellular gene transfer efficiency and target specificity. Additionally, it exhibits low hepatotoxicity and immunogenicity, forming a stable complex with minimal loss in blood even in an in vivo environment. This makes it a promising candidate for effective gene therapy applications.

Career Highlights

Youjin Na is associated with Genemedicine Co., Ltd., where he continues to advance his research and development efforts in gene therapy. His work has garnered attention for its potential to revolutionize treatment options for various diseases.

Collaborations

Youjin Na collaborates with Chae Ok Yun, contributing to the innovative research environment at Genemedicine Co., Ltd. Their partnership enhances the development of cutting-edge therapies.

Conclusion

Youjin Na's contributions to gene therapy through his adenovirus complex patent highlight his role as an influential inventor in the field. His work promises to pave the way for new therapeutic strategies in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…